A naturalistic prospective study of the use of fluoxetine in general psychiatric outpatients

Human Psychopharmacology

Volumn 11, Issue 5, 1996, Pages 365-372

  Mortimore, C ^a,c   Blacker, C V R ^b  

^a WITHINGTON HOSPITAL   (United Kingdom)

^b ROYAL CORNWALL HOSPITAL   (United Kingdom)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

fluoxetine; naturalistic; serotonin

Indexed keywords

FLUOXETINE; SEROTONIN;

ADULT; AGED; AGITATION; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BULIMIA; CHRONIC FATIGUE SYNDROME; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; DRUG TOLERANCE; DYSTHYMIA; FEMALE; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; OBSESSION; ORAL DRUG ADMINISTRATION; PANIC; PRIORITY JOURNAL;

EID: 0029955807     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199609)11:5<365::AID-HUP815>3.0.CO;2-F     Document Type: Article

References (38)

1. Asberg, M., Traskmann, L. and Thoren, P. (1976). 5HIAA in the cerebrospinal fluid ... a biochemical suicide predictor? Archives of General Psychiatry, 33, 1193-1197.
2. Asberg, M., Bertilsson, L., Martensson, B., Scalia-Tomba, G. P., Thoren, P. and Traskman-Bendz, L. (1984). CSF monoamine metabolites in melancholia. Acta Psychiatrica Scandinavica, 69, 201-219.
3. Ashby, C. R., Carr, L. A., Cook, C. L., Steptoe, M. M. and Franks, D. D. (1988). Alteration of platelet serotonergic mechanisms and monoamine oxidase activity in premenstrual syndrome. Biological Psychiatry, 24(2), 225-233.
4. Bastini, B., Avora, R. C. and Meltzer, H. Y. (1991). Serotonin uptake and imipramine binding in the blood platelets of obsessive-compulsive disorder patients. Biological Psychiatry, 30(2), 131-139.
5. Bhaumik, S., Collacott, R. A. and Gandhi, D. (1994). A study in the use of antidepressants in adults with mental retardation and affective disorders. Neuropsychopharmacology, 10(Suppl. 3S/Part 2), 162S (117-133).
6. Blacker, C. V. R. and Mortimore, C. (1996). Randomized controlled trials and naturalistic data: time for a change? Human Psychopharmacology, 11, 353-363
7. Brewerton, T. D., Mueller, E. A., Lesern, M. D., Brandt, H. A., Quearry, B., George, D. T., Murphy, D. L. and Jimerson, D. C. (1992). Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia. Archives of General Psychiatry, 49(11), 852-861.
8. Cohn, J. B. and Willcox, C. A. (1985). A comparison of fluoxetine, imipramine and placebo in patients with major depressive disorder. Journal of Clinical Psychiatry, 46(3, Pt 2), 26-31.
9. Cooper, G. L. (1988). The safety of fluoxetine - an update. British Journal of Psychiatry, 153(3), 77-86.
10. Corne, S. J. and Hall, J. R. (1989). A double-blind comparative study of fluoxetine and dothiepin in the treatment of depression in general practice. International Clinical Psychopharmacology, 4(3), 245-254.
11. Daly, C. G., Hore, B. D. and Wildegust, H. (1994). Fluoxetine and its use in patients with alcohol problems: a naturalistic field study. Neuropsychopharmacology, 10(Suppl. 3S/Part 2), 98S (58-70).
12. Ferrari, M. D. and Saxena, P. R. (1993). On serotonin and migraine: a clinical and pharmacological review. Cephalgia, 13(3), 151-165.
13. Guy, W. (1976). CGI. ECDUE Assessment Manual for Psychopharmacology. DHEW Publications revised no (ADM), pp. 76-338.
14. Halbreich, U. and Tworek, H. (1993). Altered serotonergic activity in women with dysphoric premenstrual syndromes. International Journal of Psychiatry in Medicine, 23(1), 1-27.
15. Hall, J. R. (1988). Fluoxetine: efficacy against placebo and by dose - an overview. British Journal of Psychiatry, 153(3), 59-63.
16. Hollander, E., Fay, M., Cohen, B., Campeas, R. and Gorman, J. M. (1988). Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioural findings. American Journal of Psychiatry, 145(8), 1015-1017.
17. Hollander, E., Stein, D. J., DeCaria, C. M., Cohen, L., Saoud, J. B., Skodol, A. E., Kellman, D., Rosnick, L. and Oldham, J. M. (1994). Serotonergic sensitivity in borderline personality disorder: preliminary findings. American Journal of Psychiatry, 151(2), 277-280.
18. Hollyman, J. A., Freeling, P., Paykel, E. S., Bhat, A. and Sedgwick, P. (1988). Double-blind placebo-controlled trial of amitriptyline among depressed patients in general practice. Journal of the Royal College of Practitioners, 38, 393-397.
19. Jimerson, D. C., Lesem, M. D., Kaye, W. H. and Brewerton, T. D. (1992). Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes. Archives of General Psychiatry, 49(2), 132-138.
20. Katon, W., Von Korff, M., Lin, E., Bush, T. and Ormel, J. (1992). Adequacy and duration of antidepressant treatment in primary care. Journal of Medical Care, 30, 67-76.
21. Linden, M., Osterheider, M., Nickelsen, T. and Schaat, B. (1993). Three types of early termination of antidepressant drug treatment. International Clinical Psychopharmacology, 8(4), 345-346.
22. Lopez-Ibor, J. J. Jr (1988). The involvement of serotonin in psychiatric disorders and behaviour. British Journal of Psychiatry, 153(3), 26-39.
23. McWilliam, C. and Dover, S. (1994). Naturalistic study into the use of fluoxetine in elderly depressive patients. Neuropsychopharmacology, 10(Suppl. 3S/Part 2), 101S (58-31).
24. Malmgren, R., Aberg-Wistedt, A. and Martensson, B. (1989). Aberrant seasonal variations of platelet serotonin uptake in endogenous depression. Biological Psychiatry, 25(4), 393-402.
25. Rapkin, A. J., Edelmuth, E., Chang, L. C., Reading, A. E., McGuire, M. T. and Su, T. P. (1987). Whole blood serotonin in premenstrual syndrome. Obstetrics and Gynaecology, 70(4), 533-537.
26. Sarrias, M. J., Artigas, F., Martinez, E. and Gelpin, E. (1989). Seasonal changes of plasma serotonin and related parameters: correlation with environmental measures. Biological Psychiatry, 26(7), 695-706.
27. Sharpe, M., Archard, L., Banatvala, J., Borysiewicz, L., Clare, A., David, A., Edwards, R., Hawton, K., Lambert, H., Lane, R., McDonald, E. M., Mowbray, J., Pearson, D., Peto, T., Preedy, V., Smith, A., Smith, D., Taylor, D., Tyrell, D., Wessely, S., White, P. (1991). Guidelines for research in chronic fatigue syndromes. Journal of the Royal Society of Medicine, 84, 118-121.
28. Stark, P. and Hardison, C. D. (1985). A review of multicentre controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder. Journal of Clinical Psychiatry, 46(3 Pt 2), 53-58.
29. Stokes, P. E. (1993). Fluoxetine: a five year review. Clinical Therapeutics, 15(2), 216-243.
30. Teicher, M. H., Glod, C. and Cole, J. O. (1990). Emergence of intense suicidal preoccupation during fluoxetine treatment. American Journal of Psychiatry, 147, 207-210.
31. Tollefson, G. D. (1991). Anxiety and alcoholism: a serotonin link. British Journal of Psychiatry, 159(Suppl. 12), 34-39.
32. Van Praag, H. M., Asnis, G. M., Kahn, R. S., Brown, S. L., Korn, M., Friedman, J. M. and Wetzler, S. (1990). Nosological tunnel vision in biological psychiatry. A plea for a functional psychopathology. Annals of the New York Academy of Sciences, 600, 501-510.
33. Virkkunen, M. and Linnoila, M. (1990). Serotonin in early onset, male alcoholics with violent behaviour. Annals of Medicine, 22(5), 327-331.
34. Wallin, M. S. and Rissanen, A. M. (1994). Food and mood: relationship between food, serotonin and affective disorders. Acta Psychiatrica Scandinavica, (Suppl. 377), 36-40.
35. Westenberg, H. G. and den Boer, J. A. (1989). Serotonin-influencing drugs in the treatment of panic disorder. Psychopathology, 22(Suppl. 1), 68-77.
36. Winchel, R. M. and Stanley, M. (1991). Self-injurious behaviour: a review of the behaviour and biology of self-mutilation. American Journal of Psychiatry, 148(3), 306-317.
37. Wurtman, J., Wurtman, R., Berry, E., Gleason, R., Goldberg, H., McDermott, J., Kahne, M., Tsay, R. (1993). Dexfenfluramine, fluoxetine and weight loss among female carbohydrate cravers. Neuropsychopharmacology, 9(3), 201-210.
38. Zohar, J., Mueller, E. A., Insel, T. R., Zohar-Kadouch, R. C. and Murphy, D. L. (1987). Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls. Archives of General Psychiatry, 44(11), 946-951.